Tonnaer J A, Engels G M, Voshart K, Wiegant V M, de Jong W
Brain Res Bull. 1983 Mar;10(3):295-300. doi: 10.1016/0361-9230(83)90093-x.
The binding of 3H-angiotensin II to a synaptosome-enriched fraction of the subcortical part of rat brain was studied. In this fraction specific high-affinity binding sites for angiotensin II were demonstrated. The binding sites were saturated at a ligand concentration of 2 X 10(-9) M. Scatchard analysis revealed a single class of binding sites with an apparent maximal binding capacity of 14 fmoles/mg of protein and an equilibrium dissociation constant, KD, of 0.9 X 10(-9) M. The specific binding at the KD concentration amounted to 59% of the total binding and was reversible. The association and dissociation rate constants (k1 and k-1) were 0.0212 nM-1 min-1 and 0.0196 min-1, respectively. Binding was dependent on both incubation time and tissue concentration in the incubation mixture. Angiotensins with biological activity in the brain, i.e., angiotensins I, II, III, and the fragments (3-8) and (4-8) competed with 3H-angiotensin II for the binding sites with IC50's of 9 X 10(-8) M, 2 X 10(-9) M, 4 X 10(-9) M, 4 X 10(-7) M and 4 X 10(-6), respectively. In the presence of 1 mM of the converting enzyme inhibitor SQ 14,225 the IC50 for angiotensin I was 2 X 10(-7) M. Competition by the biologically active fragment angiotensin (5-8) could not be demonstrated. The latter peptide, however, was highly metabolized during the incubation under the assay conditions used. The binding potency of the various angiotensins paralleled their dipsogenic and pressor potency. The present data indicate the possible physiological involvement of these binding sites as specific receptors in the actions of angiotensins in the brain.
研究了3H - 血管紧张素II与大鼠脑皮质下部分富含突触体的组分的结合情况。在该组分中证实了血管紧张素II的特异性高亲和力结合位点。配体浓度为2×10(-9)M时结合位点达到饱和。Scatchard分析显示存在一类结合位点,其表观最大结合容量为14 fmol/mg蛋白质,平衡解离常数KD为0.9×10(-9)M。KD浓度下的特异性结合占总结合的59%,且是可逆的。结合和解离速率常数(k1和k-1)分别为0.0212 nM-1 min-1和0.0196 min-1。结合依赖于孵育时间和孵育混合物中的组织浓度。脑内具有生物活性的血管紧张素,即血管紧张素I、II、III以及片段(3 - 8)和(4 - 8),与3H - 血管紧张素II竞争结合位点,其IC50分别为9×10(-8)M、2×10(-9)M、4×10(-9)M、4×10(-7)M和4×10(-6)。在存在1 mM转化酶抑制剂SQ 14,225的情况下,血管紧张素I的IC50为2×10(-7)M。未证实具有生物活性的片段血管紧张素(5 - 8)的竞争作用。然而,在所用测定条件下孵育期间,后一种肽高度代谢。各种血管紧张素的结合能力与其致渴和升压能力平行。目前的数据表明这些结合位点作为特异性受体可能在脑内血管紧张素的作用中具有生理参与。